These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31452588)

  • 1. Longitudinal Stent Elongation of a Tapered Lesion during Percutaneous Coronary Intervention: A Case Report.
    Matsumoto S; Sakakibara M; Nishikawa N
    Int J Angiol; 2019 Sep; 28(3):200-201. PubMed ID: 31452588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of post-dilatation on longitudinal stent elongation: An in vitro study.
    Sumi T; Ishii H; Tanaka A; Suzuki S; Kojima H; Iwakawa N; Aoki T; Hirayama K; Mitsuda T; Harada K; Negishi Y; Ota T; Kada K; Murohara T
    J Cardiol; 2018 May; 71(5):464-470. PubMed ID: 29198920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Report of Successful Procedural, Clinical, and Angiographic Outcomes with a Tapered Stent of a Patient in Naturally Tapered Coronary Vessel.
    Premchand RK; Kumar YS
    J Clin Diagn Res; 2017 Jan; 11(1):OD06-OD07. PubMed ID: 28273994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal stent deformation elongating to left main trunk.
    Matsushita K; Arakawa K; Hibi K; Kimura K; Umemura S; Himeno H
    Cardiovasc Interv Ther; 2014 Jul; 29(3):247-51. PubMed ID: 24158901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Zivelonghi C; van Kuijk JP; Nijenhuis V; Poletti E; Suttorp MJ; van der Heyden JAS; Eefting FD; Rensing BJ; Ten Berg JM; Azzalini L; van den Brink FS; Ribichini F; Colombo A; Henriques JPS; Agostoni P
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E299-E307. PubMed ID: 29411523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late in-stent restenosis after sirolimus-eluting stent implantation is related to thrombus formation-Insight from a case with IVUS, OCT, and histological findings.
    Ito S; Nakasuka K; Miyata K; Inomata M; Yoshida T; Tamai N; Suzuki S; Murakami Y; Suzuki S; Sato K
    J Cardiol Cases; 2012 Apr; 5(2):e83-e86. PubMed ID: 30532911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very late stent thrombosis occurring simultaneously in sirolimus-eluting stents and bare-metal stent in three different coronary vessels.
    Kawaguchi Y; Katayama J; Kumazawa A; Sugiyama H; Watanabe T; Wakahara N
    Cardiovasc Interv Ther; 2011 Jan; 26(1):64-9. PubMed ID: 24122502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The STENTYS® paclitaxel-eluting stent in the treatment of unprotected distal left main.
    Briguori C; Visconti G; Donahue M; Focaccio A; Mitomo S; Kawamoto H; Nakamura S
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):E131-9. PubMed ID: 25639945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ultimaster® coronary stent system: state of the art.
    Longo G; La Manna A; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2015 Jun; 63(3):193-203. PubMed ID: 25900560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
    Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
    Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stent for in-stent restenosis of left main coronary artery in takayasu arteritis.
    Furukawa Y; Tamura T; Toma M; Abe M; Saito N; Ehara N; Taniguchi R; Nakagawa Y; Kita T; Kimura T
    Circ J; 2005 Jun; 69(6):752-5. PubMed ID: 15914957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence.
    Chisari A; Pistritto AM; Piccolo R; La Manna A; Danzi GB
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan.
    Yanagi D; Shirai K; Takamiya Y; Fukuda Y; Kuwano T; Ike A; Mori K; Kubota K; Iwata A; Fujimi K; Kawamura A; Nishikawa H; Miller N; Zhang B; Tsuchiya Y; Urata H; Saku K
    J Cardiol; 2008 Apr; 51(2):89-94. PubMed ID: 18522781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial.
    Park KW; Kang SH; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Hur SH; Ryu JK; Lee BR; Park YW; Chae IH; Kim HS;
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2805-16. PubMed ID: 24814486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late giant coronary aneurysm associated with a fracture of sirolimus eluting stent: a case report.
    Okamura T; Hiro T; Fujii T; Yamada J; Fukumoto Y; Hashimoto G; Fujimura T; Yasumoto K; Matsuzaki M
    J Cardiol; 2008 Feb; 51(1):74-9. PubMed ID: 18522779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Implanting 50-60 mm-Tapered Drug Eluting Stents in Chronic Total Occlusions.
    Miñana G; Consuegra-Sánchez L; Rumiz E; Valero E; García-Blas S; Pernias V; Husser O; Fernández-Cisnal A; Sanchis J; Núñez J
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1117-1122. PubMed ID: 30878362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® - three-month results.
    Gil RJ; Bil J; Kern A; Pawłowski T
    Kardiol Pol; 2018; 76(2):464-470. PubMed ID: 29192951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
    Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
    EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.
    Rhee TM; Park KW; Kim CH; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2453-2463. PubMed ID: 30573055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.